Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibody and Peptide Therapeutics

Paul Declerck's Biography



Paul Declerck, Professor, Katholieke Universiteit Leuven

Professor Paul Declerck obtained a PhD in Pharmaceutical Sciences from the University of Leuven (Belgium) in 1984. After a post doctoral training in the Laboratory of Biochemical Cytology with Prof. Dr. de Duve at the Rockefeller University in New York (USA) he joined in 1986 the Center for Molecular and Vascular Biology at the University of Leuven. In 1991, he was appointed professor of Pharmaceutical Biotechnology at this university. He became full professor in 1997. His research is focused on structure-function relationships of (recombinant) proteins and on the development of monoclonal antibodies for research, diagnostic and therapeutic purposes. Professor Declerck has given numerous invited lectures at international meetings and has authored more than 190 scientific papers in peer-reviewed journals. He is a member of various international scientific advisory boards and vice-president of the commission of medicines for human use of the Federal Agency for Medicinal and Health Products (Belgium).

Paul Declerck Image

Biosimilars, What’s in the Name?

Thursday, 21 July 2011 at 09:00

Add to Calendar ▼2011-07-21 09:00:002011-07-21 10:00:00Europe/LondonBiosimilars, What’s in the Name? SELECTBIOenquiries@selectbiosciences.com

Being copies of complex biological molecules, biosimilars can be considered similar but not identical to their reference product. The scientific approach to their safe introduction differs significantly from that for generics. Implications for patients and healthcare professionals will be discussed and illustrated by specific examples.


Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com